SCOOTER82a_Livingstone_Frequencies of Hemoglobin Variants ...
SCOOTER82a_Livingstone_Frequencies of Hemoglobin Variants ...
SCOOTER82a_Livingstone_Frequencies of Hemoglobin Variants ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
thousands <strong>of</strong> blood preparations I examined.<br />
The question is then why it has only increased in<br />
this one malarious area. Migration is surely one<br />
<strong>of</strong> the forces contributing to its distribution, but<br />
the populations <strong>of</strong> Papua New Guinea are ethnically<br />
quite distinct from the peoples <strong>of</strong> the<br />
Malay Peninsula. The migration would have to<br />
have been very ancient and did not result in<br />
hemoglobin E being dispersed among the same<br />
peoples. This seems to be more evidence for the<br />
later diffusion <strong>of</strong> hemoglobin E, but it would also<br />
seem to raise the possibility that malaria selection<br />
is somewhat different in this area from that<br />
in Africa or the Middle Eastand India.<br />
The very high frequencies <strong>of</strong> hemoglobin E in<br />
Southeast Asia raise a similar problem. This allele<br />
is also a common mutant and, as has been previously<br />
stated, is now found occasionally in<br />
Europe and also among the Eti-Turks. Given its<br />
high frequencies in Asia, one would assume that<br />
it would have increased more than it has in other<br />
malarious areas. Again the possibility <strong>of</strong> differences<br />
in malaria selection arises, although the<br />
same species <strong>of</strong> human malaria parasite occurs<br />
in both Southeast Asia and the Africa-Middle<br />
East area. <strong>Hemoglobin</strong> C is found in high frequencies<br />
in West Africa, and hemoglobin OArab<br />
in much <strong>of</strong> the Middle East and North Africa in<br />
low frequencies. These are both the same glu<br />
Iys change found in hemoglobin E but at different<br />
positions. Since the clinical symptoms <strong>of</strong><br />
homozygosity for these two hemoglobin variants<br />
are similar to those <strong>of</strong> hemoglobin E, they would<br />
appear to have the same fitness disadvantage<br />
and probably the same advantage in heterozygotes;<br />
but with the exception <strong>of</strong> some hemoglobin<br />
C frequencies in West Africa, these two variants<br />
nowhere approach in frequency the<br />
hemoglobin E frequencies in Southeast Asia or<br />
Assam. In all cases, these glu-Iys mutants seem<br />
to be out-competed by hemoglobin S and are in<br />
the process <strong>of</strong> being replaced by it. The fact that<br />
hemoglobin S is not found in Southeast Asia but<br />
in high frequencies in Africa and the Middle East<br />
could account for these differences.<br />
Finally, the distributions <strong>of</strong> a-thalassemia in<br />
Southeast Asia and Africa seem so different as to<br />
require further factors to explain them. In most<br />
human populations, the a locus is duplicated, so<br />
that most individuals have four functional sites<br />
that produce a chains. a-thalassemia is a mutation<br />
that results in the absence <strong>of</strong> function <strong>of</strong><br />
either one or both <strong>of</strong> the a genes on a single<br />
chromosome; the single deletion is a2-thalassemia<br />
(-a) and the double deletion, al-thalassemia<br />
(- -). Homozygosity for the double deletion<br />
results in an inviable fetus with hydrops<br />
fetalis, while simultaneous heterozygosity for<br />
the single and double deletions (-al - -)<br />
causes hemoglobin H disease, which can result<br />
in varying degrees <strong>of</strong> decreased fitness. Thus,<br />
the two genes are in competition. Most estimates<br />
<strong>of</strong> the fitness values <strong>of</strong> all the genotypes<br />
imply that there are no stable polymorphism frequencies<br />
with both alleles present in a population<br />
(Wills and Londo 1981, <strong>Livingstone</strong> 1983).<br />
Most estimates also indicate that the al-thalassemia<br />
gene would be replaced, which has led to<br />
Wills and Londo calling it a "fugitive" allele.<br />
Yokoyama (1983) made a similar analysis <strong>of</strong> the<br />
a-thalassemias and concluded that a stable polymorphism<br />
can exist with both the single and<br />
double deletions present. However, his estimates<br />
<strong>of</strong> the fitness values <strong>of</strong> the various genotypes<br />
seem to be very unrealistic. Of the eight<br />
sets <strong>of</strong> fitnesses that result in a stable polymorphism,<br />
half (four) estimate the fitness <strong>of</strong> hemoglobin<br />
H disease (heterozygous for both the sin-<br />
9<br />
gle and double deletion (-al - -)) to be<br />
greater than normals or individuals with four a<br />
genes. This is impossible. For the other four sets,<br />
individuals with two a genes in the form <strong>of</strong> heterozygosity<br />
<strong>of</strong> the double deletion and the normal<br />
(- - I aa) have an increased fitness compared<br />
to normals, while those with two deletions<br />
who are homozygous for the single deletion<br />
(-al-a) have a decreased fitness. Given the<br />
phenotypic similarity <strong>of</strong> these genotypes, these<br />
estimates seem highly unrealistic. In addition,<br />
the decrease in fitness <strong>of</strong> the single deletion<br />
homozygote is as great in most cases as those<br />
with hemoglobin H disease, which again seems<br />
to me to have little evidence in its favor. Thus,<br />
more reasonable estimates <strong>of</strong> these fitness values<br />
still lead to the conclusion that no possible<br />
stable polymorphism could exist. Nevertheless,<br />
although a2-thalassemia (-a) is much more<br />
widespread and occurs in higher frequencies, a<br />
l-thalassemia (--) is found in polymorphic frequencies<br />
in the Mediterranean and is very common<br />
in Southeast Asia. I have shown that althalassemia<br />
will inhibit the increase <strong>of</strong> a2-thalassemia<br />
if it attains polymorphic frequencies first<br />
and that may have happened in Southeast Asia<br />
(<strong>Livingstone</strong> 1983). But this is still one more<br />
striking difference between Southeast Asia and<br />
other areas with many malaria polymorphisms in<br />
the Old World.<br />
Only a few <strong>of</strong> the major problems raised by<br />
current knowledge <strong>of</strong> the distribution <strong>of</strong> these<br />
red cell traits have been discussed. A perusal <strong>of</strong><br />
many <strong>of</strong> the frequencies recorded here raises<br />
many other questions. It is hoped that this compilation<br />
<strong>of</strong> the data will be useful in solving some<br />
<strong>of</strong> them and in relating this certain segment <strong>of</strong><br />
human genetic variation to human demographic,<br />
cultural, and epidemiological history.